Health Care & Life Sciences » Pharmaceuticals | Karolinska Development AB

Karolinska Development AB

Karolinska Development AB
Stock Exchange OTC Publication Venue
EPS
SEK0.49
Market Cap
SEK244.51 M
Shares Outstanding
62.92 M
Public Float
50.03 M

Profile

Address
Tomtebodavägen 23A
Solna AB 171 65
Sweden
Employees -
Website http://www.karolinskadevelopment.com
Updated 07/08/2019
Karolinska Development AB engages in the investment in pharmaceutical business. It invests in companies that develop medical innovations, specialty care products and orphan drugs for patients suffering from life-threatening and serious debilitating conditions. Its funds are obtained from independent investors and shareholders by issuing and selling shares and interest-bearing instruments.

Financials

View All

Hans Lennart Rudolf Wigzell
Chairman
Y Y Tse
Director